DeDora Capital’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.7K Buy
+599
New +$27.6K 0.01% 237
2022
Q2
– Sell
-336
Closed -$19K – 305
2022
Q1
$19K Buy
+336
New +$17.2K 0.01% 242

Other funds holding NVO

DeDora Capital's NVO Position: Q3 2026 in Review

DeDora Capital opened a new position in Novo Nordisk (NVO) in Q3 2026: 599 shares worth $22.7K. The stake represents 0.01% of the portfolio and ranks #237 among its holdings. This is a return to the name: DeDora Capital previously reported a position in NVO as recently as Q1 2022.

DeDora Capital first reported a position in NVO in Q1 2022 and has held it in 2 quarters since. 1,227 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • DeDora Capital held 599 shares of Novo Nordisk worth $22.7K as of Q3 2026.
  • Novo Nordisk was a new DeDora Capital position in Q3 2026.
  • Novo Nordisk made up 0.01% of DeDora Capital's portfolio in Q3 2026, its #237 holding.
  • DeDora Capital first reported a position in Novo Nordisk in Q1 2022 and has held it in 2 quarters since.
  • 1,227 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on DeDora Capital's 13F filing for Q3 2026, filed 26 Oct 2026.